AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2024
Dec 6, 2024
33510_dirs_2024-12-06_9cf7af00-7508-442d-8f19-59988ad24233.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-12-04
Reporting Person: HENSON HEIDI (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-04 | Common Stock | P | 25975 | $3.85 | Acquired | 25975 | Indirect |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16